Get started
Work

Outcome of Patients with Myelodysplastic Syndrome and a Monosomal Karyotype Following Allogeneic Stem Cell Transplant: Single Institution Experience

Year: 2018
Type: article
Study design: Observational Study
Abstract: Background: Myelodysplastic syndromes (MDS) are a group of heterogeneous disorders of defective myeloid maturation and differentiation. Monosomal karyotype (MK) has a poor prognosis. Allogeneic hematopoietic stem cell transplant (HSCT) remains the only potentially curative treatment. We evaluated the outcome of patients with monosomal karyotype MDS following HSCT in our institution.
DOI: 10.1016/j.bbmt.2017.12.778
Authors: Salwa S. Saadeh, Omar Alkharabsheh, Aref Al-Kali, Mrinal M. Patnaik, Mithun Vinod Shah, Mark R. Litzow, William J. Hogan, Hassan B. Alkhateeb
Institution: Mayo Clinic
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2792501308
FWCI:
Cites:
Cited by:
Related to: 10